Clinical trial

MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC

NCT02592577

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-11-01

PhasePHASE1

Study timeline

Study start (actual)2015-11-01Date precision: month

Registry last updated2025-12-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Carcinomaunresolved

Interventions

Autologous Genetically modified T cells, MAGEA10ᶜ⁷⁹⁶TBIOLOGICAL

Sponsors & collaborators

Adaptimmunelead sponsor

Mapped research locations

MadridMadrid, Spain2 HoustonTexas, United States1 BostonMassachusetts, United States1 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 St LouisMissouri, United States1 AtlantaGeorgia, United States1 MiamiFlorida, United States1 TorontoOntario, Canada1 NashvilleTennessee, United States1 LondonUnited Kingdom1 ColumbusOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02592577 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.